Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
about
Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza StrainsDetailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network.Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins.Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season.Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
P2860
Q30384943-8F7FF27E-2C20-4FA1-91ED-2FD223647425Q30392895-ED93823D-ABC3-4BB1-9331-E82630B4D377Q33899438-51044AB9-8A40-44C7-9CFA-891AC3135995Q35956533-4ACF8A47-6E7B-4C16-9665-C4FD641D3D76Q37107424-0C0ADE34-1973-445D-8E3E-9EA15B197D8EQ37591325-31B82872-70EB-4CAE-B7DE-7F82CB37B668Q38803889-86555A5B-AA00-46F3-A6C5-8D04781943FCQ39340731-D1688FBD-8D86-4286-8BA9-85E606915BDFQ39837983-0E8885B9-0E41-4EF4-92C1-B8FCCE9A321CQ40070473-2EC785A8-1D4B-41CC-93B9-255528B6392EQ41919202-0C958E42-2033-40A3-BDC8-291360673F8CQ41933365-431DF199-3532-4748-A669-ACDE80CF1202Q43167908-A2FD202B-0BCB-4527-A57D-A0BD46CE4AD8Q49057993-BA050961-752A-438F-B4A7-7857E1EEE430Q50065275-A509FBB9-18F4-43A2-8253-C0D64EF5FB21
P2860
Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@ast
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@en
type
label
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@ast
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@en
prefLabel
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@ast
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@en
P2093
P2860
P356
P1476
Persistence of Antibodies to I ...... ears of Influenza Vaccination.
@en
P2093
Emileigh Johnson
Joshua G Petrie
Rachel Truscon
Suzanne E Ohmit
P2860
P304
P356
10.1093/INFDIS/JIV313
P407
P577
2015-05-26T00:00:00Z